Monica Ferrante, DO

IM PGY-3 at @UCincyIM | Interested in Cardiology + Advanced Heart Failure and Transplant + Women's Heart Health + #MedEd | 1st Gen Med | Views = Own

[Faysal Alhasan @AlhasanFaysal]

Couldn’t be more happier to reconnect with my forever mentor and big brother @md_SsAhmad, and the future super star fellow @MFerranteDO @UCincyIM @MCWcardiology

[Saad Ahmad, MD @SaadAhmadMD]

Great seeing old and new trainees presenting their work and even better having a mini reunion @RefaatMostafaMD @MFerranteDO @AlhasanFaysal

[Cincinnati IM Residency @CincyIntMed]

We’re incredibly proud of our outstanding PGY3, @D_E_McDuffie, for presenting his work on applying implementation science to enhance adherence to spontaneous breathing trials in our medical ICU! Way to go David! @CincyIM @accpchest #CHEST2024

[JACC Journals @JACCJournals]

#GCOS2024 #JACCCardioOnc SimPub: #SGLT2i administration was associated with a significantly decreased risk of developing cancer therapy-related cardiac dysfunction in patients with #T2DM and cancer. https://t.co/3PbC3N3EpS

#GCOS24 #CardioOnc #Diabetes #T2D @AmmarWB @SarjuGanatraMD @AnaBaracCardio @datsunian @Richardkcheng2 @anita_deswal

[Edgardo Alania @Ed_Alania]

🔵 TTR amyloid cardiomyopathy: Literature review & red-flag symptom clusters for each cardiology specialty @ESC_Journals #cardioEd #Cardiology #Amyloidosis

[European Society of Cardiology Journals @ESC_Journals]

#ARNI in #HF with ESRD + dialysis: ⬆️LVEF ➕⬇️☠️ with no risk of hypotension ➕ hyperkalaemia.
👉MA: https://t.co/fVmaXJFbra

@AmrAbdin10 @EJHFEiC @GiuseppeGalati_ @HanCardiomd @JanBiegus #EJHF

[Carlos Collet MD PhD @ColletCarlos]

The game just changed in cardiology! 🫀

Coronary CT #CCTA can now assess coronary microvascular dysfunction – a huge leap forward in diagnosing and treating microvascular disease. 🌟

This could reshape how we approach #CMD

🔥Just published @JACCJournals https://t.co/29oD74bmRD

[American Society of Echocardiography @ASE360]

Check out this excellent article by @CardioBusiness about our new #ASEGuideline, "Recommendations for Multimodality Imaging of Patients With Left Ventricular Assist Devices and Temporary Mechanical Support!"

[Monica Ferrante, DO @MFerranteDO]

Had an incredible time at my first American Society of Nuclear Cardiology conference presenting a case series highlighting the various arrhythmias that cardiac sarcoidosis can present with. Nuclear imaging has proven 🔑 to early identification of infiltrative CM. #ASNC24

[Naveen Rathi @Nrathi21]

Grateful for the opportunity to present a very interesting case on cardiac sarcoidosis at the American Society of Nuclear Cardiology conference!!
@MyASNC #ASNC2024
@UCincyIM @uccardiology
@PourriahiMD

[American College of Cardiology @ACCinTouch]

Nothing to ‘SCOFF’ at! New research out of #ESCCongress suggests fasting prior to cath lab procedures requiring conscious sedation may not be needed. Read more: https://t.co/JKiz6lvan9

[Ahmed Mohsen @drahmedmohsen85]

Female gender was removed from CHADS-VASc score in new ESC guidelines for management of AF.
Rationale : female gender is a risk modifier rather than risk factor for stroke.
Now we have a CHADS-VA score.

[Monica Ferrante, DO @MFerranteDO]

Exciting news🫀🤩

[Abbott Cardiovascular @AbbottCardio]

BREAKING 📰: The US FDA has approved a shift in #HeartFailure management after the ARIES-HM3 trial revealed aspirin avoidance had positive results for newly implanted adult #HeartMate3 #LVAD patients.

Learn more: https://t.co/cGekuCcm5D

US Safety Info: https://t.co/gBlQdYVfVK

[Monica Ferrante, DO @MFerranteDO]

@UCincyIM

[Monica Ferrante, DO @MFerranteDO]

Journal Club Noon Report with one of our favorite future cardiologists @Nrathi21 discussing REDUCE-AMI 🫀

[JACC Journals @JACCJournals]

In the VALOR-HCM placebo-controlled trial of #mavacamten for symptomatic obstructive #cvHCM hypertrophic cardiomyopathy, mavacamten improved mitral valve SAM and regurgitation. https://t.co/4U6AwzvceK

#JACCIMG @PaulCremerMD @DesaiMilindY @jeffreygeske

[American College of Cardiology @ACCinTouch]

The ARTESIA trial showed that anticoagulation reduces adverse events compared with aspirin among patients with subclinical #AFib.

Read updates to the trial on treatment differences according to CHA2DS2-VASc: https://t.co/2tKL321etp #Stroke

[FTC @FTC]

FTC releases interim staff report on Prescription Drug Middlemen: https://t.co/YY8sm4TvSs #PBMs /1

[Soleil Shah, MD MSc @SoleilShahMD]

Our new paper in @NEJM examines the widespread acquisitions of medical practices by UnitedHealth, Humana, Cigna, and other insurers—what’s driving this trend and what are its implications for patients and clinicians? 1/x

[MyJSCAI @MyJSCAI]

🚨Exciting News! #JSCAI is accepted for PubMed Central Indexing!🎉

Read @AlexandraLansky's editorial:
➡️https://t.co/eQVlmXEXYV

📢This significant milestone boosts our authors' visibility, citation rates, and recognition by making all articles more accessible to researchers and practitioners.

♥️Thank you to our Editors, Authors, Reviewers, and everyone for their unwavering support in making this possible. @SCAI